Merck KGaA Stock price

Equities

MRK

DE0006599905

Pharmaceuticals

Delayed Xetra 12:35:13 2024-03-28 pm EDT 5-day change 1st Jan Change
163.6 EUR +2.12% Intraday chart for Merck KGaA +1.24% +13.53%
Sales 2024 * 21.29B 22.94B Sales 2025 * 22.55B 24.3B Capitalization 71.13B 76.65B
Net income 2024 * 2.97B 3.2B Net income 2025 * 3.45B 3.72B EV / Sales 2024 * 3.65 x
Net Debt 2024 * 6.51B 7.01B Net Debt 2025 * 4.44B 4.79B EV / Sales 2025 * 3.35 x
P/E ratio 2024 *
24.1 x
P/E ratio 2025 *
20.5 x
Employees 62,908
Yield 2024 *
1.36%
Yield 2025 *
1.47%
Free-Float 29.71%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.12%
1 week+1.24%
Current month+3.68%
1 month+2.99%
3 months+14.77%
6 months+4.97%
Current year+13.53%
More quotes
1 week
156.50
Extreme 156.5
164.85
1 month
153.75
Extreme 153.75
164.85
Current year
140.50
Extreme 140.5
164.85
1 year
134.30
Extreme 134.3
176.75
3 years
134.30
Extreme 134.3
231.50
5 years
76.22
Extreme 76.22
231.50
10 years
56.30
Extreme 56.3
231.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 20-07-12
Director of Finance/CFO 53 19-04-25
Chief Tech/Sci/R&D Officer - 18-12-31
Members of the board TitleAgeSince
Director/Board Member 75 14-05-08
Director/Board Member - -
Chairman 67 19-04-25
More insiders
Date Price Change Volume
24-03-28 163.6 +2.12% 371,656
24-03-27 160.2 +0.69% 299,813
24-03-26 159.1 -0.31% 255,538
24-03-25 159.6 -1.36% 165,432
24-03-22 161.8 +0.12% 209,833

Delayed Quote Xetra, March 28, 2024 at 12:35 pm EDT

More quotes
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
163.6 EUR
Average target price
181.1 EUR
Spread / Average Target
+10.68%
Consensus
  1. Stock
  2. Equities
  3. Stock Merck KGaA - Xetra